Figure - available from: Therapeutic Advances in Gastroenterology
This content is subject to copyright.
Box and dot plot of FC levels 3 months before, within 1 month of, and 2–6 months after CDI in the IBD-CDI cohort. FC levels for controls were recorded according to the infection episode landmark. p Values for comparisons are shown above the plots. CDI, Clostridioides difficile infection; FC, fecal calprotectin; IBD, inflammatory bowel disease.
Source publication
Background
Clostridioides difficile infection (CDI) is a clinical challenge associated with poor outcomes in patients with inflammatory bowel disease (IBD).
Objectives
To identify clinical risk factors for CDI and its recurrence among patients with IBD.
Design
Case–control cohort study of IBD patients with and without episodes of CDI.
Methods
A...
Similar publications
Background
Fatigue is a burdensome symptom of Crohn’s disease (CD) and ulcerative colitis (UC). The Communicating Needs and Features of IBD Experiences (CONFIDE) study investigated how patients and health care professionals (HCPs) in the United States (US) and Europe (France, Germany, Italy, Spain, and the United Kingdom) perceived the experiences...